Drugs / Sulbutiamine
Sulbutiamine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| — | NCT06497647 Comparator | Mar → Sep 2024 overdue | nocturnal enuresis | Sohag University | Recruiting | No outcome recorded |
Evidence & citations 7 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Sulbutiamine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06497647 ↗ |
| Known as | Bisibuthiamine | ChEMBL registry synonym — accepted as the source's own label CHEMBL1874002 ↗ |
| Known as | Sulbutiamina | ChEMBL registry synonym — accepted as the source's own label CHEMBL1874002 ↗ |
| Known as | Thiamine disulfide o,o-diisobutyrate | ChEMBL registry synonym — accepted as the source's own label CHEMBL1874002 ↗ |
| Known as | Youvitan | ChEMBL registry synonym — accepted as the source's own label CHEMBL1874002 ↗ |
| Modality | Small molecule | — CHEMBL1874002 ↗ |
| Route | Oral | “sulbutiamine will be used by oral route 100 mg daily for 1 month” NCT06497647 ↗ |